LACHENAIE, QC, June 19, 2012 /CNW Telbec/ - Capital Pro-Égaux Inc. (the "Company") reports that on Thursday June 14th, 2012, the "Company" has filed, through its wholly owned subsidiary
Technique d'usinage Sinlab Inc., notices against Nobel Biocare USA,
Nobel Biocare Procera USA, Dentsply International Inc, Cagenix
Technologies Inc, Materialise Dental Inc, BioHorizons Global HQ, DelCam
Holdings and DelCam USA Inc for patent infringement of the "Company"
United States Patent Nos. 8,021,153, 7,866,980, 7,331,786, 6,814,575
This notice, amongst various requests, formally requires to immediately
ceasing the manufacturing and the selling of manufacturing programs of
the superstructure and/or the surgical guide for dental implant
placement covered by the patents and to respond in writing by no later
than the 5th of July 2012, 17:00 hours. Failure to comply will generate
immediate legal proceedings
About Pro-Égaux Inc.
Pro-Égaux through its wholly owned subsidiary, Technique d'usinage
Sinlab Inc., is a company based in Lachenaie, Quebec, specializing
mainly in the conception and design of titanium products to be used in
the dental prosthesis restoration industry.
"Neither TSX Venture Exchange nor its Regulation Services Provider (as
that term is defined in the policies of the TSX Venture Exchange)
accepts responsibility for the adequacy or accuracy of this release."
SOURCE CAPITAL PRO-EGAUX INC.
For further information:
Capital Pro-Égaux Inc.
Tel.: (514) 616-0612
Fax: (450) 226-1923